Allopurinol Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 100 mg, 300 mg
Reference Brands: Aloprim(US & EU)
Category:
Arthritis
Allopurinol inhibits xanthine oxidase, reducing uric acid production. It prevents gout flare-ups, kidney stones, and urate crystal formation. Benefits include long-term uric acid control, decreased gout attacks, kidney protection, and improved quality of life. It’s a key drug for managing hyperuricemia and gout complications.
Allopurinol tablets is available in Oral Tablets
and strengths such as 100 mg, 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Allopurinol tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Allopurinol tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Allopurinol tablets are approved in the EU and US for managing hyperuricemia and gout. In the EU, brands like Zyloric (by Sanofi) are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data and biosimilarity, with generic options available. Both regions require detailed dossiers for approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for allopurinol tablets, ensuring adherence to European and American standards for safe, effective long-term uric acid management and gout prevention.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing